Deephaven Scales DSCR Lending Nationwide with Lightning Docs API Integration

Wind Creek Chicago Southland Awarded LEED® Silver Building Certification

Silicom to Participate in 21st Annual Needham Technology, Media, & Consumer Conference

EMA Webinar to Reveal New Research on SD-WAN to SASE Transition Best Practices

PeachSkinSheets' Signature Comforter Recognized for Style and Comfort by Oprah Daily

The Homecare Agency Training Caregivers With AI and Virtual Reality Just Won Two Awards -- and It's Redefining What Dementia and Parkinson's Care at Home Looks Like

New toolkit for obesity care helps clinicians integrate lifestyle interventions with obesity medications

UFP Packaging Expands National Pallet Manufacturing Network, Strengthening Coast-to-Coast Reach

NFID Urges Everyone to Put Their "Hands In" for Better Health

M-tron Industries, Inc. Reminds Investors of Upcoming Investor Day on May 12, 2026

Hansen Chosen to Deliver AI‑Enabled SaaS CIS for Los Angeles County Waterworks Districts

J.S. Held Has Earned Great Place To Work® Certification™ for Fourth Consecutive Year

VyStar Credit Union Selects Diebold Nixdorf's Branch Automation Solutions to Optimize Its Self-Service Network

Global Millennial Capital Raises USD 100 Million to Fund New-Age Technology Leaders in Underpenetrated Mid-Cap Segments

Nick Snyder joins American Global Strategies as Senior Vice President

EQB secures final approval for PC Financial acquisition and prepares for closing to bring competitive change to Canadian banking

Built by Lawyers, Tailored by You: Harvey Launches Purpose-Built Legal Agents Across Every Major Practice Area

Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease

SKS HONORED WITH 2026 RED DOT DESIGN AWARD FOR FLAGSHIP CHICAGO SHOWROOM AT THE MART

THE FRAGRANCE FOUNDATION HIGHLIGHTS MOTHER'S DAY GIFTING WITH A BLOOM OF FRUIT-FORWARD AND FLORAL SCENTS

Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn's disease

High Profile Cannabis Opens Its First Kentucky Dispensary in London

AbbVie Highlights New Long-Term Data Advancing Treatment Standards in Inflammatory Bowel Diseases (IBD) at 2026 Digestive Disease Week®

COhatch, Eyrie Cocktail Lounge Opens in Hamilton Investing in the City's Future

Support Egg Quality and Ovulation with Nature's Bounty® New Fertility Supplement*

Los Angeles Holds Top Spot as Worst City for Mosquitoes as Activity Climbs Nationwide

LINE-X Accelerates National Footprint with Robust 2026 Expansion Pipeline

PNC Announces Redemption of 4.543% Senior Fixed Rate/Floating Rate Notes Due May 13, 2027

Peabody Reports Results for the Quarter Ended March 31, 2026

Peabody Board Declares Dividend on Common Stock